2 Bay Area Biotechs That Jumped While Its Peers Cratered Post author:Sam Post published:February 6, 2018 Post category:BioPharma Since Friday, the stock market has been volatile, to say the least. Source: BioSpace You Might Also Like NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017 VEXIM Acquired by Stryker in EUR 183M Deal October 24, 2017 FDA Clears Massachusetts Biotech Tesaro's Ovarian Cancer PARP Inhibitor March 27, 2017
NW Bio Closes 3-Year Convertible Debt Exchange And Financing, And Completes Payoff Of Last $5 Million Of 2014 Bonds June 21, 2017
